Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
<p>Abstract</p> <p>Background</p> <p>Immunohistochemical detection of prostate specific antigen (PSA) is widely used to identify metastatic prostatic adenocarcinoma. However, PSA may not be expressed in some poorly differentiated prostatic carcinomas and its immunoreact...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Diagnostic Pathology |
Online Access: | http://www.diagnosticpathology.org/content/2/1/41 |